Strength
50 mg/.5mL
Manufacturer
Janssen Biotech, Inc.NDC
57894007001
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/2/2026
Active Ingredients
GOLIMUMABApproval Type
Biologic (BLA)
FDA Application
BLA125289On Market Since
4/25/2009
Pharmacological Classes
Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity
Related Drugs
Same classification
REMICADE 100 MG VIAL
Brand
57894003001•Janssen Biotech, Inc.
$1135.9660
per EA
ENBREL 25 MG/0.5 ML SYRINGE
Brand
58406001004•Immunex Corporation
$2076.2308
per ML
ENBREL 50 MG/ML SYRINGE
Brand
58406002104•Immunex Corporation
$2080.7423
per ML
ENBREL 50 MG/ML MINI CARTRIDGE
Brand
58406004404•Immunex Corporation
$2081.5847
per ML
ENBREL 50 MG/ML SURECLICK
Brand
58406003204•Immunex Corporation
$2083.3498
per ML
CIMZIA 2X200 MG/ML(X3)START KT
Brand
50474071081•UCB, Inc.
$6072.5137
per EA
CIMZIA 2X200 MG/ML SYRINGE KIT
Brand
50474071079•UCB, Inc.
$6112.3912
per EA